Article Details

AstraZeneca plc 22.2% potential upside indicated by Barclays - DirectorsTalk Interviews

Retrieved on: 2023-09-29 18:33:02

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca plc 22.2% potential upside indicated by Barclays - DirectorsTalk Interviews. View article details on hiswai:

Excerpt

Barclays set a target price of 13,500 GBX for the company, which when compared to the AstraZeneca plc share price of 11,046 GBX at opening today ...

Article found on: www.directorstalkinterviews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up